SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shilpa Medicare informs about financial results

16 Nov 2015 Evaluate

With reference to the earlier Announcement dated November 07, 2015, regarding Financial Results for Sept 30, 2015, Shilpa Medicare has informed that there was some typographical errors while entering details in Part II of UFR i.e. Shareholding Details. There is no change in Part I.

The above information is a part of company’s filings submitted to BSE.

 

Shilpa Medicare Share Price

444.20 7.95 (1.82%)
11-May-2026 11:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1885.45
Dr. Reddys Lab 1292.00
Cipla 1341.15
Zydus Lifesciences 947.60
Lupin 2247.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×